FindTrial
Sign In

A study on chronic hair loss in women - possible mechanisms

A PILOT INVESTIGATIVE STUDY TO ASSESS JAK STAT SIGNALLING IN CHRONIC TELOGEN EFFLUVIUM

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033731
Enrollment
40
Registered
2021-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L650- Telogen effluvium

Interventions

None listed

Sponsors

IADVL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CTE: Persistent hair shedding beyond 6 months with no trigger discernible on clinical evaluation or investigations including CBC/LFT/KFT/ VIT D3/TFT/ANA/Blood sugar/ serum ferritin/ serum folate/ Vit B12 (as per attached case record form) with absence of features suggestive of androgenetic alopecia on trichoscopy

Exclusion criteria

Exclusion criteria: Both cases and controls: • Systemic co-morbidites (Chronic illness/ hypothyroidism/ surgery / HTN/DM/Asthma /TB/PCOD/any other) • systemic/topical drugs • pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
To see the relevance of jak stat pathway in CTETimepoint: At completion of IHC procedure. 1 year—

Secondary

MeasureTime frame
to seek pharmacological relevance of jak stat pathway in CTETimepoint: 1 year—

Countries

India

Contacts

Public ContactAnanta Khurana

Dr. Ram Manohar Lohia and Post Graduate Institute of Medical Education and Research

drananta2014@gmail.com9212370467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026